HRT Financial’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,069
| Closed | -$1.03M | – | 3099 |
|
|
2023
Q2 | $1.03M | Buy |
10,069
+7,376
| +274% | +$752K | 0.01% | 868 |
|
|
2023
Q1 | $244K | Sell |
2,693
-26,589
| -91% | -$2.41M | ﹤0.01% | 1677 |
|
|
2022
Q4 | $1.11M | Sell |
29,282
-11,035
| -27% | -$419K | 0.02% | 837 |
|
|
2022
Q3 | $1.01M | Buy |
+40,317
| New | +$1.01M | 0.01% | 855 |
|
|
2021
Q2 | – | Sell |
-4,961
| Closed | -$494K | – | 3511 |
|
|
2021
Q1 | $494K | Buy |
+4,961
| New | +$494K | 0.01% | 1613 |
|
|
2020
Q4 | – | Sell |
-12,767
| Closed | -$1.24M | – | 2565 |
|
|
2020
Q3 | $1.24M | Buy |
12,767
+5,668
| +80% | +$552K | 0.04% | 372 |
|
|
2020
Q2 | $1.11M | Buy |
7,099
+5,308
| +296% | +$828K | 0.03% | 459 |
|
|
2020
Q1 | $258K | Buy |
+1,791
| New | +$258K | 0.02% | 420 |
|